fashion -WSS

fashion

author：fashion 2025-09-30 17:28:50 - browse：197

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： The untold story of TV’s first prescription drug ad

WSS

Fetal cell organoids grown from amniotic fluid, study finds

New Alzheimer's drugs heat up race for early detection blood tests

He's 19 months old and has one of the world’s rarest diseases

Ozempic has benefits for kidney disease as well as diabetes

State of the Union pitch: Bigger Medicare drug price negotiations

Will the FTC rein in IQVIA's health data empire?

hotspot

fashion

hotspot

How one medical school became remarkably diverse

Will the FTC rein in IQVIA's health data empire?

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Jerome Adams on the need for new antivirals for Covid

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Tori Bowie and the unacceptable rates of Black maternal death

Stem cell biologist probes earliest stages of human development

Hepatitis C has a cure — but many Americans still lack access to it

$1 billion proposal to grow Boston, Massachusetts biotech

focus

Former reverend arrested for allegedly killing 8

Will the FTC rein in IQVIA's health data empire?

Dems pitch expanding Medicare power to negotiate drug prices

Ozempic has benefits for kidney disease as well as diabetes

State of the Union pitch: Bigger Medicare drug price negotiations

Why patients can’t get everything they want on drug pricing

focus

focus

explore

knowledge